Global Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic), by Therapy (Lactating Period, Dry Period (Antibiotics, and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America), is estimated to be valued at US$ 1,423.5 Million in 2022 and is estimated to exhibit a CAGR of 5.2% during the forecast period (2022-2030).

Recent product launches for the treatment of bovine mestitis by key players is expected to drive growth of the global bovine mastitis market growth during the forecast period. For instance, in October 2018, Boehringer Ingelheim International GmBH announced the launch of a new medicine called ‘Lockout’, which is designed to avoid post-immunotherapy problems such as allergies and infections in dairy cattle, hence improving their health and performance.

Global Bovine Mastitis Market– Impact of Coronavirus (COVID-19) Pandemic

COVID-19 pandemic has affected various industries globally. The players operating in the global bovine mastitis market are facing challenges on various fronts due to the COVID-19 pandemic. COVID-19 disease has affected the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. The COVID-19 had a minimal effect on the supply chain for bovine mastitis products. However, due to limited operations in veterinary pharmacies, containment techniques including lockdown and social distancing have caused problems such as delay in pharmaceutical supplies. According to a report by Zoetis in April 2020, there has been no significant influence on the product supply chain of medication for bovine mestitis treatment, and key players are in close touch with the U.S. Food and Drug Administration to keep them updated about the shortage or production delays. Despite the pandemic's lockdown and social distancing efforts, demand for dairy products has surged.

Browse 53 Market Data Tables and 39 Figures spread through 204 Pages and in-depth TOC on “Global Bovine Mastitis Market, by Type (Clinical Mastitis and Sub-clinical Mastitis), by Product (Antibiotics, Vaccines, Pain Killers, and Others), by Route of Administration (Intra-mammary and Systemic) by Therapy (Lactating Period, Dry Period (Antibiotics and Teat Sealants)), by End User (Veterinary Centers, Hospital, Clinics, and Others), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)- Forecast to 2030” 

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/bovine-mastitis-market-4947

Technological advances in the field of drug discovery and development for the treatment of clinical mastitis is expected to propel the market growth. For instance, in July 2020, Zoetis, Inc. entered into a partnership with Trianni, Inc. to develop transgenic monoclonal antibody platforms for the development of innovative veterinary therapies such as bovine mestitis treatment.

Key Takeaways of the Global Bovine Mastitis Market:

  • The global bovine mastitis market is expected to exhibit a CAGR of 5.2% during the forecast period, owing to enhancements of products such as teat sealants. For instance, Boehringer Ingelheim stated in April 2021 that its internal teat sealant Ubroseal would be upgraded to Ubroseal Blue to prevent new intramammary infections throughout the dry season.
  • Among type, clinical mastitis segment is expected to dominate the global bovine mastitis market, owing to high incidence rate of clinical mastitis. For instance, according to an article published by BMC Veterinary Research on October 2020, a study conducted on a big commercial dairy farm with around 2,500 Holstein cows, showed the incidence rate for clinical bovine mastitis, among other types of bovine mestitis, was 21.9% on the farm. Clinical mastitis was most common in temperate zone, according to the findings.
  • Among product, antibiotics segment is the leading segment in the global bovine mastitis market, as other classes of medications such as vaccines and pain killers for the treatment of mastitis are few, antibiotics are the treatment of choice for bovine mestitis for a growing number of dairy farms.
  • Among regions, North America is expected to hold a dominant position in the market. The regional market will benefit from the growing use of Intra-mammary infusion in the treatment of bovine mastitis. The presence of major key players in this region such a Zoetis, Elanco and others will not only help the regional market grow, but will also have an impact on worldwide market growth along with developing innovative treatment options for bovine mastitis in numerous countries including France, Germany, and the United Kingdom, is expected to drive the Europe market growth.
  • Major players operating in the global bovine mastitis market include Zoetis, Merck & Co., Inc., Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health, Norbrook, DeLaval, ImmuCell Corporation, Advanced Animal Diagnostics, and Nimrod Veterinary Products Ltd.

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo